Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print RSS Feed

Breaking News

April 2, 2014
To develop compounds for the potential treatment of cancer  Read More »
April 2, 2014
Gains gene therapy programs for hemophilia treatments  Read More »
April 1, 2014
Kellerman to oversee strategy and execution of clinical programs  Read More »
April 1, 2014
Offers R&D incentive for French companies  Read More »
April 1, 2014
Adds Trianni Mouse to biologic research capabilities  Read More »
April 1, 2014
Brandreth to head quality and compliance functions for clinical trials   Read More »
Kristin Brooks
April 1, 2014
Woodfield to continue manufacturing existing Pernix products  Read More »
April 1, 2014
Coughlin to head global manufacturing activities  Read More »
April 1, 2014
Penn to provide Phase III materials and commercial production  Read More »
April 1, 2014
To evaluate biomarkers for the discovery of novel therapies   Read More »
April 1, 2014
Stay tuned for Contract Pharma's Newsmaker interview with CEO, James Foster   Read More »
March 31, 2014
Buck brings 20 years of project management experience  Read More »
March 31, 2014
Survey explores current state of clinical outsourcing and partnership models  Read More »
March 31, 2014
Gains development and commercialization rights in the U.S., Canada and Japan  Read More »
March 31, 2014
Beal to further incorporate patient needs in Sanofi offerings  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On